Insider Selling: Outset Medical, Inc. (NASDAQ:OM) CEO Sells 33,227 Shares of Stock

Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg sold 33,227 shares of the stock in a transaction that occurred on Monday, January 13th. The shares were sold at an average price of $0.81, for a total value of $26,913.87. Following the completion of the sale, the chief executive officer now directly owns 861,397 shares of the company’s stock, valued at $697,731.57. This represents a 3.71 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Leslie Trigg also recently made the following trade(s):

• On Tuesday, January 7th, Leslie Trigg sold 10,227 shares of Outset Medical stock. The shares were sold at an average price of $1.29, for a total transaction of $13,192.83.
• On Friday, November 15th, Leslie Trigg sold 5,645 shares of Outset Medical stock. The stock was sold at an average price of $0.80, for a total value of $4,516.00.

Outset Medical Trading Down 12.2 %

NASDAQ:OM traded down $0.11 during trading hours on Monday, hitting $0.81. 1,885,376 shares of the stock were exchanged, compared to its average volume of 2,853,379. The company’s 50 day moving average is $1.01 and its two-hundred day moving average is $1.41. The company has a market capitalization of $42.44 million, a P/E ratio of -0.29 and a beta of 2.05. Outset Medical, Inc. has a twelve month low of $0.44 and a twelve month high of $5.22. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12.

Institutional Investors Weigh In On Outset Medical

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. GSA Capital Partners LLP lifted its holdings in Outset Medical by 924.7% during the third quarter. GSA Capital Partners LLP now owns 1,111,612 shares of the company’s stock worth $753,000 after acquiring an additional 1,003,135 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Outset Medical by 118.5% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 1,538,859 shares of the company’s stock valued at $5,925,000 after purchasing an additional 834,663 shares in the last quarter. Millennium Management LLC increased its stake in Outset Medical by 58.8% during the 2nd quarter. Millennium Management LLC now owns 1,942,899 shares of the company’s stock worth $7,480,000 after purchasing an additional 719,412 shares in the last quarter. Marshall Wace LLP raised its holdings in Outset Medical by 487.8% during the 2nd quarter. Marshall Wace LLP now owns 314,187 shares of the company’s stock worth $1,210,000 after buying an additional 260,740 shares during the period. Finally, Point72 Asset Management L.P. bought a new position in Outset Medical in the second quarter valued at approximately $827,000.

Analyst Ratings Changes

Separately, Royal Bank of Canada reiterated a “sector perform” rating and set a $3.00 target price on shares of Outset Medical in a research report on Tuesday, January 7th.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.